Blackstone Life Sciences will provide $400 million to support development of duvakitug, a human monoclonal antibody targeting TL1ADuvakitug is currently in phase 3...
Seatrec, a leader in thermal-powered, long-endurance subsea drones, today announced the successful launch of a collaborative scientific mission to develop new autonomous profiling...
Blackstone Life Sciences and Anthos Therapeutics, Inc., a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of cardiometabolic diseases, announced that Novartis...
Blackstone Life Sciences and Anthos Therapeutics, Inc. (Anthos or the company), a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of...
